Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A multicentre randomised phase III trial comparing pembro... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
0
Authors
Sanjay Popat
22 more
Sanjay Popat
•
Alessandra Curioni‐Fontecedro
20 more
•
Rolf Stahel
Published
September 22, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.annonc.2020.09.009
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.annonc.2020.09.009
License
publisher-specific-oa
